NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D projects for the development of drugs for malaria and neglected tropical diseases (NTDs).2 ...
Researchers on Wednesday reported two promising new approaches to counteract malaria's growing resistance to medication -- one involving a new class of drugs. Switzerland-based Novartis released ...
Researchers have developed a new microscopy method that uses a magnetic field and polarized light to provide quantitative ...
Despite decades of efforts to combat it, malaria remains a major global health threat. According to the World Health ...
Add Yahoo as a preferred source to see more of our stories on Google. This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. ...
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results